series-b
Stage
2
Investors
About
Cadence Neuroscience develops a personalized neuromodulation medical device system designed to detect brain signals and deliver targeted electrical stimulation to treat drug-resistant epilepsy. The technology was incubated at Mayo Clinic and combines proven hardware with new software for improved seizure control.
Explore Cadence Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.